Suppr超能文献

SUMO化修饰调控孕激素受体转录活性的潜在机制。

Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.

作者信息

Abdel-Hafiz Hany, Dudevoir Michelle L, Horwitz Kathryn B

机构信息

Department of Medicine, Division of Endocrinology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado 80045, USA.

出版信息

J Biol Chem. 2009 Apr 3;284(14):9099-108. doi: 10.1074/jbc.M805226200. Epub 2009 Feb 11.

Abstract

Posttranslational modification by small ubiquitin-like modifier (SUMO) is a major regulator of transcription. We previously showed that progesterone receptors (PR) have a single consensus psiKXE SUMO-conjugation motif centered at Lys-388 in the N-terminal domain of PR-B and a homologous site of PR-A. SUMOylation of the PR is hormone-dependent and has a suppressive effect on transcription of an exogenous promoter. Here we show that repression of PR activity by SUMOylation at Lys-388 is uncoupled from phosphorylation, involves synergy between tandem progesterone response elements, and is associated with lowered ligand sensitivity and slowed ligand-dependent down-regulation. However, paradoxically, cellular overexpression of SUMO-1 increases PR transcriptional activity even if Lys-388 is mutated, suggesting that the receptors are activated indirectly by other SUMOylated proteins. One of these is the coactivator SRC-1, whose binding to PR and enhancement of agonist-dependent N-/C-terminal interactions is augmented by the presence of SUMO-1. Increased transcription due to SRC-1 is independent of PR SUMOylation based on assays with the Lys-388 mutants and the pure antiprogestin ZK98299, which blocks N-/C-terminal interactions. In summary, SUMOylation tightly regulates the transcriptional activity of PR by repressing the receptors directly while activating them indirectly through augmented SRC-1 coactivation.

摘要

小泛素样修饰物(SUMO)介导的翻译后修饰是转录的主要调节方式。我们之前发现,孕激素受体(PR)在PR-B的N端结构域中存在一个位于赖氨酸-388的单一共有psiKXE SUMO结合基序,PR-A也有一个同源位点。PR的SUMO化修饰是激素依赖性的,对外源启动子的转录具有抑制作用。在此我们发现,赖氨酸-388位点的SUMO化对PR活性的抑制作用与磷酸化无关,涉及串联孕激素反应元件之间的协同作用,并且与配体敏感性降低和配体依赖性下调减慢有关。然而,矛盾的是,即使赖氨酸-388发生突变,细胞中SUMO-1的过表达仍会增加PR的转录活性,这表明受体是被其他SUMO化蛋白间接激活的。其中之一是共激活因子SRC-1,SUMO-1的存在增强了它与PR的结合以及对激动剂依赖性N端/C端相互作用的增强作用。基于对赖氨酸-388突变体和纯抗孕激素ZK98299的检测,由于SRC-1导致的转录增加与PR的SUMO化无关,ZK98299可阻断N端/C端相互作用。总之,SUMO化通过直接抑制受体,同时通过增强SRC-1共激活间接激活受体,从而严格调控PR的转录活性。

相似文献

1
Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.
J Biol Chem. 2009 Apr 3;284(14):9099-108. doi: 10.1074/jbc.M805226200. Epub 2009 Feb 11.
2
Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation.
BMC Mol Biol. 2012 Mar 22;13:10. doi: 10.1186/1471-2199-13-10.
3
Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1.
J Biol Chem. 2003 Apr 4;278(14):12335-43. doi: 10.1074/jbc.M207148200. Epub 2003 Jan 14.
4
Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.
Mol Endocrinol. 2007 Dec;21(12):2890-906. doi: 10.1210/me.2007-0248. Epub 2007 Aug 23.
9
Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14287-92. doi: 10.1073/pnas.0905118106. Epub 2009 Aug 17.
10
Sumoylated SnoN represses transcription in a promoter-specific manner.
J Biol Chem. 2006 Nov 3;281(44):33008-18. doi: 10.1074/jbc.M604380200. Epub 2006 Sep 11.

引用本文的文献

2
Progesterone Receptor Signaling in the Uterus Is Essential for Pregnancy Success.
Cells. 2022 Apr 27;11(9):1474. doi: 10.3390/cells11091474.
3
Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor.
Biochem Biophys Res Commun. 2020 Dec 17;533(4):879-885. doi: 10.1016/j.bbrc.2020.09.058. Epub 2020 Sep 29.
5
An Approach to Greater Specificity for Glucocorticoids.
Front Endocrinol (Lausanne). 2018 Mar 13;9:76. doi: 10.3389/fendo.2018.00076. eCollection 2018.
7
The transcriptional repressor GATAD2B mediates progesterone receptor suppression of myometrial contractile gene expression.
J Biol Chem. 2017 Jul 28;292(30):12560-12576. doi: 10.1074/jbc.M117.791350. Epub 2017 Jun 2.
8
Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.
Mol Cancer Res. 2016 Feb;14(2):141-62. doi: 10.1158/1541-7786.MCR-15-0431. Epub 2015 Nov 17.
9
Progesterone action in breast, uterine, and ovarian cancers.
J Mol Endocrinol. 2015 Apr;54(2):R31-53. doi: 10.1530/JME-14-0252. Epub 2015 Jan 13.

本文引用的文献

2
Progesterone receptor isoforms in normal and malignant breast.
Ernst Schering Found Symp Proc. 2007(1):77-107.
4
SUMO: getting it on.
Biochem Soc Trans. 2007 Dec;35(Pt 6):1409-13. doi: 10.1042/BST0351409.
5
Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.
Mol Endocrinol. 2007 Dec;21(12):2890-906. doi: 10.1210/me.2007-0248. Epub 2007 Aug 23.
6
Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors.
Biochemistry. 2007 Jul 10;46(27):8036-49. doi: 10.1021/bi7004575. Epub 2007 Jun 16.
7
SUMO and NF-kappaB ties.
Cell Mol Life Sci. 2007 Aug;64(15):1979-96. doi: 10.1007/s00018-007-7005-2.
8
Regulation of SRC family coactivators by post-translational modifications.
Cell Signal. 2007 Jun;19(6):1101-12. doi: 10.1016/j.cellsig.2007.02.002. Epub 2007 Feb 20.
9
A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.
Mol Endocrinol. 2007 May;21(5):1066-81. doi: 10.1210/me.2006-0524. Epub 2007 Mar 13.
10
CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.
EMBO J. 2007 Apr 4;26(7):1831-42. doi: 10.1038/sj.emboj.7601602. Epub 2007 Mar 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验